Nomencature Used by BiopharmaView™ Software for N-Gylcan Names


日期: 11/15/2018
类别: Academia Omics , Pharma CRO , BioPharmaView Software

0 投票数
   打印    评价文章:

For research use only. Not for use in diagnostic procedures.


Answer

BioPharmaView™ software uses predefined N-glycan structures, or software users have the option to build their own custom modifications. Typically, the Ludger N-glycan product names (e.g., A1, A2, A1F) are used. Focusing on the number of sialic acid residues present in each modification, this nomenclature system is limited and is only able to describe a few simple glycans. 

A custom modification created in BioPharmaView software can be given any name, but it needs to be unique. (The creation of custom modifications is described under the topic Add a User-Defined Modification in the BioPharmaView software Help module.) Once a custom modification is created, it remains available for other projects or experiments that are processed at a later date.

The linked document describes the different naming conventions for N-glycan structures (https://www.ludger.com/docs/info-guides/ludger-igg-glycan-names.pdf).